Incretin mimetics administered by auto-injectors or pens enable significant weight reduction and offer an important means of ...

In this video, Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA, discusses notable updates across several areas of cardiology ...

The growing prevalence of diabetes, primarily due to obesity, aging populations, and sedentary lifestyles, is a key factor ...

New research to be presented at the European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that patients ...

In this retrospective cohort study, tirzepatide dispensations were found to have increased significantly following approval ...

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper ...

Report Ocean has released a market research report on the Incretin-Based Drugs industry, covering 150+ countries and analyzing over 1,00000 published and forthcoming reports per year. The report, ...

Announced preclinical data demonstrating the bioequivalence of RT-114, a GLP-1/GLP-2 dual agonist (PG-102) delivered orally via the RaniPill® ...

The rising prevalence of obesity has prompted the development of effective weight loss treatments. Several peptide hormones have a key role in appetite regulation and metabolism, but the discovery ...

Dublin, April 10, 2025 (GLOBE NEWSWIRE) -- The "Incretin-based Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...